A method for treating
asthma in a subject includes inserting a therapy delivery device into a vessel of a subject. The therapy delivery device is advanced to a point substantially adjacent an intraluminal
target site of the
autonomic nervous system. Next, the therapy delivery device is activated to deliver a therapy
signal to the intraluminal
target site to treat the
asthma. The intraluminal
target site is in electrical communication with
nervous tissue selected from the group consisting of a
spinal nerve, pre- or post-ganglionic autonomic fibers, a sympathetic chain
ganglion, a thoracic sympathetic chain
ganglion, a cervical
ganglion, a lower cervical ganglion, an inferior cervical ganglion, an intramural ganglion, a splanchnic nerve, an esophageal
plexus, a cardiac
plexus, a pulmonary
plexus, an anterior pulmonary plexus, a posterior pulmonary plexus, a celiac plexus, a hypogastric plexus, an inferior mesenteric ganglion, a celiac ganglion, and a superior mesenteric ganglion.